145416-34-8: Emtricitabine 2-Epimer

Emtricitabine 2-Epimer or 2-epi-Emtricitabine (CAS No.145416-34-8) or 4-Amino-5-fluoro-1-[(2S,5S)-2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) in combination with other antiviral agents it shows activity against HIV. It is approved for use in combination therapy.

Additional information on CAS 145416-34-8

Catalogue No.

VE008051

CAS No.

145416-34-8

Molecular Formula

C8H10FN3O3S

Molecular Weight

247.25 g/mol

Parent drug

Emtricitabine

IUPAC Name

4-Amino-5-fluoro-1-[(2S, 5S)-2- (hydroxymethyl)-1, 3-oxathiolan-5-yl]-2-(1H)-pyrimidone

Synonyms

2-epi-Emtricitabine

References

'Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://doi.org/10.2165/00003495-200363220-00003. ?Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https'

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

145416-34-8: Emtricitabine 2-Epimer

145416-34-8: Emtricitabine 2-Epimer
Catalogue No.

VE008051

CAS No.

145416-34-8

Molecular Formula

C8H10FN3O3S

Molecular Weight

247.25 g/mol

Parent drug

Emtricitabine

IUPAC Name

4-Amino-5-fluoro-1-[(2S, 5S)-2- (hydroxymethyl)-1, 3-oxathiolan-5-yl]-2-(1H)-pyrimidone

Synonyms

2-epi-Emtricitabine

References

'Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://doi.org/10.2165/00003495-200363220-00003. ?Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https'

Status

In-stock

ListName

Emtricitabine 2-Epimer

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden